Anti-TB Drugs: And Then There Were None

See allHide authors and affiliations

Science  18 Jul 2008:
Vol. 321, Issue 5887, pp. 364
DOI: 10.1126/science.321.5887.364

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Two crucial antituberculosis drugs, capreomycin and cycloserine, are valued today precisely because they didn't seem valuable a short time ago.